DCipher Markets (@DCipherMarkets) header
DCipher Markets (@DCipherMarkets) profile picture

Decoding Market Noise into Clarity, Strategy & Better Decisions.

Mumbai, Chandigarh
Joined March 2025
🚨 F&O BAN RADAR | 11-11-2026 | Who's Next? Several stocks are approaching the F&O ban threshold, with interesting shifts in market positioning. 🔎 What to track? • MWPL utilisation — how close to the 95% ban threshold? • OI build-up — fresh longs or shorts? • Price + OI — is positioning strengthening or unwinding? • Options volume & IV — is activity heating up? ⚠️ Remember: F&O ban restricts fresh positions, not existing ones. Which stock will enter the ban list next? — DCipher #FnO #StockMarketIndia #Nifty #BankNifty #DCipherMarkets #BANDHANBNK #AMBUJACEM #MANAPPURAM #kaynes #SAIL #inoxwind
1
4
192
Broader Market Trend as of 9th Nov 2026 EOD Stocks Above 20EMA - 1943 (⬇️ -99 vs day before) Stocks Below 20EMA - 1130 (⬆️ +122 vs day before) Breadth Weakened 🔴 #MarketTrends #MarketInsight #MarketUpdates #GIFTNIFTY #Nifty #Sensex #IndianStockMarket #SmallCaps
1
4
235
Broader Market Trend as of 6th Nov 2026 EOD Stocks Above 20EMA - 1663 (⬇️ -348 vs day before) Stocks Below 20EMA - 1359 (⬆️ +347 vs day before) Breadth Weakened 🔴 #MarketTrends #MarketInsight #MarketUpdates #GIFTNIFTY #Nifty #Sensex #IndianStockMarket #SmallCaps
1
3
196
Does Muhurat Trading set the tone for the week ahead? Over the last 10 years: - 8 out of 10 weeks ended positive. - Average return: +0.86%. - Best year: 2019 (+2.71%). - Worst year: 2016 (-1.49%). A positive Muhurat session doesn't guarantee a positive week. And a negative one doesn't necessarily signal weakness. Festive sentiment is one thing. Market direction is another. — DCipher #NIFTY50 #MuhuratTrading #IndianStockMarket #MarketAnalysis #DCipherMarkets #HappyDiwali
1
1
3
224
May you always have the wisdom to see the light, even in the darkest moments. Wishing you and your family a very Happy and Prosperous Diwali 🙏 - DCipher #HappyDiwali #HappyDiwali2026 #शुभ_दीपावली
1
3
222
📊 Q2 FY27 RESULTS | #SUPRIYA Supriya Lifescience reported Q2 FY27 standalone net profit of ₹29.25 crore, down 42.0% year on year. • Revenue: ₹206.3 crore vs ₹199.83 crore a year ago; Net Profit: ₹29.25 crore vs ₹50.43 crore a year ago. • Operating profit (EBITDA): ₹45.4 crore, with an operating margin of 22.0%. 💡 Perspective: This marks a 42.0% decline in net profit year on year, alongside a revenue increase of 3.2% compared to last year. 🎯 What it means for you: Next to watch: Q3 FY27 results, expected by 14 Feb 2027. #SUPRIYA #Pharmaceuticals #Nifty #StockMarketIndia #StocksToWatch #StocksInFocus #MarketUpdate
3
136
📊 Q2 FY27 RESULTS | #PYRAMID Pyramid Technoplast reported Q2 FY27 EBITDA of ₹19.54 crore, up 63.8% year on year. • Q2 FY27 EBITDA of ₹19.54 crore vs ₹11.93 crore in Q2 FY26. • EBITDA margin expanded by 79 bps to 8.21% from 7.42% YoY. 💡 Perspective: This is an increase in EBITDA and margin performance compared to the previous year. 🎯 What it means for you: Next to watch: Q3 FY27 results (quarter ending 31 Dec 2026) are due by 14 Feb 2027. #PYRAMID #Plastics #Nifty #StockMarketIndia #StocksToWatch #StocksInFocus #MarketUpdate
3
111